University of Illinois At Chicago — Chicago, Illinois

University of Illinois At Chicago is a clinical research site located in Chicago, Illinois, United States 60607.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Illinois At Chicago has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Sturge-Weber Syndrome, Head and Neck Cancer, Relapsed/Refractory Follicular Non-Hodgkin Lymphoma.

Sponsors: University of Illinois at Chicago, Incyte Biosciences International Sàrl, BeiGene.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Illinois At Chicago?

University of Illinois At Chicago has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Illinois At Chicago conducted?

University of Illinois At Chicago has 3 clinical trials on record, with 2 currently active. Their work covers Sturge-Weber Syndrome, Head and Neck Cancer, Relapsed/Refractory Follicular Non-Hodgkin Lymphoma.

Is University of Illinois At Chicago accredited by Crixeo Health?

University of Illinois At Chicago has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Illinois At Chicago?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.